Genie Bailey, MD, FASAM, DLFAPA

Chief of Research and Asso Clinical Professor
Stanley Street Treatment and Resources & Brown University

Poster(s):

• (266) Dosing to effect with weekly and monthly subcutaneous buprenorphine: post-hoc analysis of a Phase 3, open-label study
  Wednesday, October 29, 2025